Clinical Trials Related to Glioblastoma Multiforme

Related studies linked through entity extraction aliases.

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Status: COMPLETED
Phase: PHASE2

Genetic Analysis of Brain Tumors

Status: TERMINATED
Phase: N/A

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Status: COMPLETED
Phase: PHASE1

Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma

Status: COMPLETED
Phase: PHASE1/PHASE2

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Status: COMPLETED
Phase: PHASE1

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Status: COMPLETED
Phase: PHASE2